Invesco’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-422,563
Closed -$35.9M 3819
2019
Q4
$35.9M Sell
422,563
-273,681
-39% -$18.3M 0.01% 1131
2019
Q3
$34.8M Sell
696,244
-38,804
-5% -$1.55M 0.01% 1142
2019
Q2
$26.8M Buy
735,048
+162,299
+28% +$5.3M 0.01% 1282
2019
Q1
$16M Sell
572,749
-124,298
-18% -$2.93M 0.01% 1355
2018
Q4
$13.3M Sell
697,047
-228,386
-25% -$5.31M 0.01% 1366
2018
Q3
$27.7M Buy
925,433
+396,660
+75% +$14.9M 0.01% 1092
2018
Q2
$19.4M Buy
528,773
+227,512
+76% +$7.39M 0.01% 1258
2018
Q1
$9.92M Buy
301,261
+106,187
+54% +$3.32M ﹤0.01% 1541
2017
Q4
$5.33M Buy
195,074
+18,056
+10% +$556K ﹤0.01% 1947
2017
Q3
$6.56M Sell
177,018
-69,702
-28% -$2.57M ﹤0.01% 1802
2017
Q2
$9.38M Sell
246,720
-732,482
-75% -$32.6M ﹤0.01% 1595
2017
Q1
$47.9M Sell
979,202
-439,902
-31% -$20.1M 0.02% 809
2016
Q4
$48.2M Sell
1,419,104
-60,295
-4% -$2.14M 0.02% 793
2016
Q3
$55.8M Sell
1,479,399
-135,274
-8% -$5.1M 0.02% 709
2016
Q2
$54.3M Sell
1,614,673
-229,234
-12% -$8.08M 0.02% 722
2016
Q1
$58.6M Sell
1,843,907
-451,886
-20% -$14.8M 0.02% 670
2015
Q4
$85.7M Sell
2,295,793
-679,059
-23% -$25.7M 0.03% 564
2015
Q3
$113M Sell
2,974,852
-407,329
-12% -$14.3M 0.05% 438
2015
Q2
$96.8M Buy
3,382,181
+532,006
+19% +$14.8M 0.04% 527
2015
Q1
$79.9M Buy
2,850,175
+938,866
+49% +$26.4M 0.03% 603
2014
Q4
$52.9M Buy
1,911,309
+202,830
+12% +$5.03M 0.02% 770
2014
Q3
$38.1M Buy
1,708,479
+346,452
+25% +$8.8M 0.02% 921
2014
Q2
$39.6M Sell
1,362,027
-764,123
-36% -$20.4M 0.02% 909
2014
Q1
$60.4M Buy
2,126,150
+413,943
+24% +$13.7M 0.02% 699
2013
Q4
$66.1M Buy
1,712,207
+145,309
+9% +$5.2M 0.03% 667
2013
Q3
$52.5M Buy
1,566,898
+196,234
+14% +$6.25M 0.02% 745
2013
Q2
$42.2M Buy
+1,370,664
New +$45.9M 0.02% 798

Other funds holding MDCO

Invesco's MDCO Position: Q1 2020 in Review

Invesco sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 422,563 shares — an estimated $35.9M sold.

Invesco first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $113M in Q3 2015. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Invesco reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Invesco sold 422,563 Medicines Co shares in Q1 2020, an estimated $35.9M.
  • Invesco first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
  • Invesco's Medicines Co position peaked at $113M in Q3 2015.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Invesco's 13F filing for Q1 2020, filed 15 May 2020.